Vx Therapy Clinical Outcomes

Harvard MedTech is an innovative company that partners with leading medical and research organizations nationwide. Together, we conduct groundbreaking research to continuously enhance the Vx Therapy Platform.

Our evidence-based approach and cutting-edge technology provides prescribed patients with the tools to achieve lasting improvement from trauma-related symptoms.

Our Research Partners

The Lancet – Randomized Controlled Study Comparing Virtual Reality to Traditional Sedation During Epidural Injection Procedures
(Peer Reviewed, Randomized Controlled Clinical Trial)

Lancet Study Comparing Virtual Reality to Traditional Sedation During Epidural Injections

A randomized controlled study comparing virtual reality to traditional sedation during epidural injection procedures. The trial included 146 patients undergoing epidural injection procedures at 6 hospitals in Thailand and the United States.

View study

North American Spine Society Journal
(Peer Reviewed Publication)

Vx Therapy Reduced Pain, Anxiety, and Depression in Patients with Chronic Cervical and Lumbar Pain

A total of 145 patients with chronic spondylitic pain (63 cervical, 46 noradicular lumbar, 36 radicular lumbar) were enrolled into a guided 14-week VR + CBT program (Vx Therapy). PROMIS measures of overall daily pain intensity, behavior, interference, anxiety, and depression were recorded at baseline and conclusion of the program.

View study

Pain and Therapy Journal
(Peer Reviewed Publication)

Combining Virtual Reality and Behavioral Health to Promote Pain Resiliency

This retrospective cohort study evaluated the effectiveness of a home-based pain relief program that utilized virtual reality and behavioral health for treating acute and chronic pain. It Includes 36 patients with acute and chronic pain secondary to workplace injuries.

View study